
Tetrahedron p. 16061 - 16082 (1997)
Update date:2022-09-26
Topics:
Okawa, Tomohiro
Osakada, Naoto
Eguchi, Shoji
Kakehi, Akikazu
(2-Oxo-1,2-dihydropyridin-3-yl)-1,3,5-triazine derivatives 10 were obtained unexpectedly, in stead of pyrido[2,3-d]pyrimidine derivatives, by the intermolecular aza-Wittig reaction of methyl 2-(N- triphenylphosphoranylidene)aminonicotinate 3 with aryl isocyanates followed by attempted heterocylization by use of prim-amines. A novel sequential aza- Wittig / cycloaddition / ring-transformation mechanism for the formation of 10 has been reported based on the isolation and characterization of the key intermediates, pyrido[1,2-a][1,3,5]triazines 15 formed via [4+2] cycloaddition of the initially produced carbodiimide with aryl isocyanates.
View MoreKaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Shanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Contact:86-21-58226973
Address:No 351,Guoshoujing Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China
Doi:10.1039/b207031f
(2002)Doi:10.1021/jo00919a029
(1974)Doi:10.1016/S0040-4039(97)10142-3
(1997)Doi:10.1021/acs.joc.9b03425
(2020)Doi:10.1002/jlcr.2590090204
(1973)Doi:10.1039/b208819c
(2002)